SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-094231
Filing Date
2022-08-25
Accepted
2022-08-25 07:46:24
Documents
14
Period of Report
2022-08-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2224531d1_8k.htm   iXBRL 8-K 28360
2 EXHIBIT 99.1 tm2224531d1_ex99-1.htm EX-99.1 17581
6 GRAPHIC tm2224531d1_ex99-1img001.jpg GRAPHIC 4863
  Complete submission text file 0001104659-22-094231.txt   232019

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20220825.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20220825_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20220825_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2224531d1_8k_htm.xml XML 3606
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 221192999
SIC: 2836 Biological Products, (No Diagnostic Substances)